VS-6766+Abema+Fulv in Met HR+/HER- BC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

VS-6766+Abema+Fulv in Met HR+/HER- BC — Stella

Home/Breast Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

United States

Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Brigham and Women's Hospital, Boston, Massachusetts

Dana Farber Cancer Institite, Boston, Massachusetts

Key details

Phase

Early testing / Safety & dosing

Sponsor

Adrienne G. Waks

Collaborators

Verastem, Inc., Eli Lilly and Company

Enrollment target

~63 participants

Started

February 2023

Primary completion

December 2027

Age range

18 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.